NARI vs. SOLV, SNN, PEN, GKOS, STVN, BLCO, INSP, PRCT, NVST, and IRTC
Should you be buying Inari Medical stock or one of its competitors? The main competitors of Inari Medical include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Stevanato Group (STVN), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Envista (NVST), and iRhythm Technologies (IRTC). These companies are all part of the "medical equipment" industry.
Inari Medical vs.
Inari Medical (NASDAQ:NARI) and Solventum (NYSE:SOLV) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, community ranking, risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends.
In the previous week, Solventum had 4 more articles in the media than Inari Medical. MarketBeat recorded 7 mentions for Solventum and 3 mentions for Inari Medical. Solventum's average media sentiment score of 0.97 beat Inari Medical's score of 0.23 indicating that Solventum is being referred to more favorably in the news media.
Solventum has higher revenue and earnings than Inari Medical.
Solventum has a net margin of 0.00% compared to Inari Medical's net margin of -13.68%. Solventum's return on equity of 0.00% beat Inari Medical's return on equity.
Inari Medical currently has a consensus target price of $68.00, suggesting a potential downside of 14.52%. Solventum has a consensus target price of $68.29, suggesting a potential downside of 7.21%. Given Solventum's higher probable upside, analysts plainly believe Solventum is more favorable than Inari Medical.
91.0% of Inari Medical shares are owned by institutional investors. 10.6% of Inari Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Inari Medical received 65 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 57.89% of users gave Inari Medical an outperform vote while only 5.56% of users gave Solventum an outperform vote.
Summary
Inari Medical and Solventum tied by winning 7 of the 14 factors compared between the two stocks.
Get Inari Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for NARI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Inari Medical Competitors List
Related Companies and Tools
This page (NASDAQ:NARI) was last updated on 1/18/2025 by MarketBeat.com Staff
